This report contains market size and forecasts of Biologic Therapeutics Drugs in global, including the following market information:
- Global Biologic Therapeutics Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Biologic Therapeutics Drugs Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Biologic Therapeutics Drugs companies in 2021 (%)
The global Biologic Therapeutics Drugs market was valued at 331750 million in 2021 and is projected to reach US$ 490710 million by 2028, at a CAGR of 5.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Avian Cell Culture Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biologic Therapeutics Drugs include Pfizer, AstraZeneca, Novartis, Merck, Smith Medical, GlaxoSmithKline, Concord Biotech, Aurobindo Pharma and H. Lundbeck and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biologic Therapeutics Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biologic Therapeutics Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Biologic Therapeutics Drugs Market Segment Percentages, by Type, 2021 (%)
- Avian Cell Culture
- Yeast
- Bacteria
- Insects Cell Culture
- Transgenics
Global Biologic Therapeutics Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Biologic Therapeutics Drugs Market Segment Percentages, by Application, 2021 (%)
- Rheumatoid Arthritis
- Anemia
- Cancer
- Diabetes
- Others
Global Biologic Therapeutics Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Biologic Therapeutics Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biologic Therapeutics Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Biologic Therapeutics Drugs revenues share in global market, 2021 (%)
- Key companies Biologic Therapeutics Drugs sales in global market, 2017-2022 (Estimated), (MT)
- Key companies Biologic Therapeutics Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- AstraZeneca
- Novartis
- Merck
- Smith Medical
- GlaxoSmithKline
- Concord Biotech
- Aurobindo Pharma
- H. Lundbeck
- Retractable Technologies
